This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
In doing so it’s compounded pre-existing pressure with pharma, where schedules are shrinking and policies are often already restrictive enough to build barriers for effective physician engagement. The threat of disease spread and other risk factors from COVID-19 have only compounded this.
A recent pharmaphorum webinar on digital transformation , held in association with P360, explored how COVID has fast-tracked pharma’s long-held ambitions to make wider use of digital technology and streamline its communications with HCPs. Physician access issues coupled with message delivery disconnects only compounded the problem.
BMHCC is simultaneously focused on the challenges of reducing acute care drug spend and improving their drug delivery model, with IV preparation and diversion detection as the chief drug delivery concerns. The goal is to move pharmacists and other clinicians to the center of patientcare where they can practice at the top of their license.
BMHCC is simultaneously focused on the challenges of reducing acute care drug spend and improving their drug delivery model, with IV preparation and diversion detection as the chief drug delivery concerns. The goal is to move pharmacists and other clinicians to the center of patientcare where they can practice at the top of their license.
This education can be delivered through various formats, such as webinars, videos, and written materials. What works for one patient group may not be effective for another, making it difficult to create universally accessible engagement tools and programs.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content